Mechanism of Action: Histamine Receptor Antagonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: Histamine Receptor Antagonists
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | BENZTROPINE MESYLATE | benztropine mesylate | INJECTABLE;INJECTION | 209442-001 | Oct 14, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Aspen Global Inc | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 204713-002 | Apr 14, 2015 | AA | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hikma Farmaceutica | BENZTROPINE MESYLATE | benztropine mesylate | INJECTABLE;INJECTION | 090287-001 | Aug 31, 2009 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Aspen Global Inc | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 204713-003 | Apr 14, 2015 | AA | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |